Welcome to CDC Stacks | Learning from the patient: Human factors engineering in outpatient parenteral antimicrobial therapy - 42131 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Learning from the patient: Human factors engineering in outpatient parenteral antimicrobial therapy
  • Published Date:
    Mar 02 2016
  • Source:
    Am J Infect Control. 44(7):758-760.


Public Access Version Available on: July 01, 2017 information icon
Please check back on the date listed above.
Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Outpatient parenteral antimicrobial therapy (OPAT) practices among adult infectious disease physicians
    Personal Author:
    Lane, Michael A.; Marschall, Jonas; Beekmann, Susan E.; Polgreen, Philip M.; Banerjee, Ritu; Hersh, Adam L.; Babcock, Hilary M.;
    Published:
    May 09 2014
    Source:
    Infect Control Hosp Epidemiol. 35(7):839-844.
    Description:
    Objective : To identify current outpatient parenteral antibiotic therapy practice patterns and complications. : Methods : We administered an 11 question survey to adult infectious disease physicians participating in the Emerging Infections Network (E...
    File Type:
    Filetype[PDF - 528.60 KB]
  2. Patient attrition from the HIV antiretroviral therapy program at two hospitals in Haiti
    Personal Author:
    Puttkammer, Nancy H.; Zeliadt, Steven B.; Baseman, Janet G.; Destiné, Rodney; Domerçant, Jean Wysler; Coq, Nancy Rachel Labbé; Raphael, Nernst Atwood; Sherr, Kenneth; Tegger, Mary; Yuhas, Krista; Barnhart, Scott;
    Published:
    Oct 2014
    Source:
    Rev Panam Salud Publica. 36(4):238-247.
    Description:
    Objective : To identify factors associated with antiretroviral therapy (ART) attrition among patients initiating therapy in 2005–2011 at two large, public-sector department-level hospitals, and to inform interventions to improve ART retention. : Me...
    File Type:
    Filetype[PDF - 564.29 KB]
  3. Parenteral Transmission of the Novel Human Parvovirus PARV4
    Personal Author:
    Simmonds, Peter; Manning, Ashleigh; Kenneil, Rachel; Carnie, Frances W.; Bell, Jeanne E.;
    Published:
    Sep 2007
    Source:
    Emerg Infect Dis. 13(9):1386-1388.
    Description:
    Transmission routes of PARV4, a newly discovered human parvovirus, were investigated by determining frequencies of persistent infections using autopsy samples from different risk groups. Predominantly parenteral routes of transmission were demonstrat...
    File Type:
    Filetype[PDF - 244.17 KB]
  4. Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors
    Personal Author:
    Charurat, Man; Oyegunle, Modupe; Benjamin, Renata; Habib, Abdulrazaq; Eze, Emeka; Ele, Prince; Ibanga, Iquo; Ajayi, Samuel; Eng, Maria; Mondal, Prosanta; Gebi, Usman; Iwu, Emilia; Etiebet, Mary-Ann; Abimiku, Alash'le; Dakum, Patrick; Farley, John; Blattner, William;
    Published:
    May 11 2010
    Source:
    PLoS One. 5(5).
    Description:
    Background : Substantial resources and patient commitment are required to successfully scale-up antiretroviral therapy (ART) and provide appropriate HIV management in resource-limited settings. We used pharmacy refill records to evaluate risk factors...
    File Type:
    Filetype[PDF - 284.53 KB]
  5. Patient Retention, Clinical Outcomes and Attrition-Associated Factors of HIV-Infected Patients Enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007–2010
    Personal Author:
    Mutasa-Apollo, Tsitsi; Shiraishi, Ray W.; Takarinda, Kudakwashe C.; Dzangare, Janet; Mugurungi, Owen; Murungu, Joseph; Abdul-Quader, Abu; Woodfill, Celia J. I.;
    Published:
    Jan 29 2014
    Source:
    PLoS One. 2014; 9(1).
    Description:
    Background : Since establishment of Zimbabwe's National Antiretroviral Therapy (ART) Programme in 2004, ART provision has expanded from <5,000 to 369,431 adults by 2011. However, patient outcomes are unexplored. : Objective : To determine improvement...
    File Type:
    Filetype[PDF - 346.06 KB]